Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus Associated Granuloma

Lignende værker

• Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency
  af: Perelygina, Ludmila, et al.
  Udgivet: (2017)
• Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies
  af: Perelygina, Ludmila, et al.
  Udgivet: (2016)
• Rubella virus-associated chronic inflammation in primary immunodeficiency diseases
  af: Perelygina, Ludmila, et al.
  Udgivet: (2020)
• Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies
  af: Perelygina, Ludmila, et al.
  Udgivet: (2019)
• Prevalence of Granulomas in Patients with Primary Immunodeficiency Disorders, United States: Data from National Healthcare Claims and the US Immunodeficiency Network Registry
  af: Leung, Jessica, et al.
  Udgivet: (2018)